The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis

BACKGROUND: Age is closely related to the efficacy of treatment for non-small cell lung cancer (NSCLC) patients. Latest clinical trials have proved the better overall survival (OS) for the use of immune checkpoint inhibitors verse chemotherapy in NSCLC patients. However, we had no clear idea of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Oncol
Main Authors: Zheng, S.-Y., Cui, H.-J., Duan, H., Peng, Y.-M., Li, Q., Sun, C.-Y., Zhang, J.-Y., Shen, W., Zhang, X., Tan, K., Jiang, X.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260274/
https://ncbi.nlm.nih.gov/pubmed/31748961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-019-02241-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados